Influence of Gender on Long-term Prognosis of Patients With Chronic Heart Failure Seen in Heart Failure Clinics

被引:14
|
作者
Jimenez-Navarro, Manuel F. [1 ]
Ramirez-Marrero, Miguel A. [1 ]
Anguita-Sanchez, Manuel [2 ]
Carlos Castillo, Juan [2 ]
机构
[1] Hosp Clin Univ Virgen de la Victoria Malaga, Serv Cardiol, Malaga 29007, Spain
[2] Hosp Reina Sofia Cordoba, Serv Cardiol, Malaga, Spain
关键词
CONVERTING-ENZYME-INHIBITORS; SEX; MANAGEMENT; CARDIOLOGISTS; MORTALITY; BURDEN;
D O I
10.1002/clc.20476
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Controversy exists concerning the influence of gender in the prognosis of patients with heart failure and no evidence is available from specific heart failure clinics. Hypothesis: Women with ambulatory heart failure are managed differently than men, although their prognosis might be better than men. Methods and Results: We analyzed the clinical characteristics, complementary test results, treatment, and prognosis in 4720 patients with chronic heart failure seen in 62 specialized clinics forming part of a multicenter registry during a mean follow-up of 40 months. The mean age was 65 +/- 12 years and 71% were men. The men were younger than the women and more often had a history of hyperlipidemia and ischemic heart disease. The men had a more advanced heart failure New York Heart Association (NYHA) functional class (III-IV) than the women and a greater frequency of systolic ventricular dysfunction. The men more often received treatment with beta-blockers, vasodilators, and antiplatelet aggregators as well as higher mean doses as compared with the women. The overall survival after the follow-up was similar for both genders, although the women had lower rates of survival free of admission for heart failure. Conclusions: Despite themortality of women and men with heart failure being similar, the rate of readmission for heart failure is greater in women in specialized heart failure clinics. These results may be associated with the pharmacological treatment differences observed.
引用
收藏
页码:E13 / E18
页数:6
相关论文
共 50 条
  • [1] The effects of atorvastatin on long-term prognosis in patients with chronic heart failure.
    Xie, RQ
    Cui, W
    Liu, F
    Hao, YM
    Zu, XG
    Du, J
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (8B): : 60D - 61D
  • [2] A severity index study of long-term prognosis in patients with chronic heart failure
    Xu, Xiao-Rong
    Meng, Xian-Chen
    Wang, Xin
    Hou, Dong-Yan
    Liang, Yan-Hong
    Zhang, Zhi-Yong
    Liu, Jia-Mei
    Zhang, Juan
    Xu, Lin
    Wang, Hua
    Zhao, Wen-Shu
    Zhang, Lin
    LIFE SCIENCES, 2018, 210 : 158 - 165
  • [3] THE SEVERITY INDEX RESEARCH OF LONG-TERM PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE
    Xu, Xiaorong
    Meng, Xianchen
    Wang, Xin
    Chen, Zhe
    Zhang, Lin
    JOURNAL OF HYPERTENSION, 2018, 36 : E103 - E104
  • [4] LONG-TERM PROGNOSIS OF PATIENTS WITH CONGESTIVE HEART-FAILURE
    MATOBA, M
    MATSUI, S
    HIRAKAWA, T
    AOYAMA, T
    TAKEDA, F
    ASAJI, T
    DOYOUSITA, H
    ENYAMA, H
    FUKUOKA, T
    NAKATOU, H
    EMOTO, J
    TAKEKOSHI, N
    MURAKAMI, E
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1990, 54 (01): : 57 - 61
  • [5] Impact of Worsening Heart Failure on Long-Term Prognosis in Patients With Heart Failure With Reduced Ejection Fraction
    Chimed, Surenjav
    Stassen, Jan
    Galloo, Xavier
    Meucci, Maria Chiara
    van der Bijl, Pieter
    Knuuti, Juhani
    Delgado, Victoria
    Marsan, Nina Ajmone
    Bax, Jeroen J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 184 : 63 - 71
  • [6] Relation of daily activity levels in patients with chronic heart failure to long-term prognosis
    Walsh, JT
    Charlesworth, A
    Andrews, R
    Hawkins, M
    Cowley, AJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (10): : 1364 - 1369
  • [7] Presence of desmin in cardiomyocytes and long-term prognosis in patients with heart failure
    Gil, R.
    Pawlak, A.
    Walczak, E.
    Rdzanek, H.
    Niemirka, T.
    Rzezak, J.
    Seweryniak, P.
    EUROPEAN HEART JOURNAL, 2005, 26 : 380 - 380
  • [8] Cessation of Spironolactone Worsens Long-term Prognosis of Heart Failure Patients
    Nakayama, Masaharu
    Takahashi, Jun
    Ito, Kenta
    Matsumoto, Yasuharu
    Ito, Yoshitaka
    Tsuburaya, Ryuji
    Shiroto, Takashi
    Takagi, Yusuke
    Hao, Kiyotaka
    Shimokawa, Hiroaki
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S158 - S158
  • [9] Multidisciplinary Cardiac Rehabilitation and Long-Term Prognosis in Patients With Heart Failure
    Kamiya, Kentaro
    Sato, Yukihito
    Takahashi, Tetsuya
    Tsuchihashi-Makaya, Miyuki
    Kotooka, Norihiko
    Ikegame, Toshimi
    Takura, Tomoyuki
    Yamamoto, Takanobu
    Nagayama, Masatoshi
    Goto, Yoichi
    Makita, Shigeru
    Isobe, Mitsuaki
    CIRCULATION-HEART FAILURE, 2020, 13 (10) : E006798
  • [10] Hemoglobin Kinetics and Long-term Prognosis in Heart Failure
    Diez-Lopez, Carles
    Lupon, Josep
    de Antonio, Marta
    Zamora, Elisabet
    Domingo, Mar
    Santesmases, Javier
    Troya, Maria-Isabel
    Boldo, Maria
    Bayes-Genis, Antoni
    REVISTA ESPANOLA DE CARDIOLOGIA, 2016, 69 (09): : 820 - 826